Transaction · 0001193125-26-416950

MILNE GEORGE M JR

MILNE GEORGE M JR, DIR, reported an open-market or private sale at Amylyx Pharmaceuticals, Inc. involving 30000.000000 shares for an estimated $830904.00. Reported holdings after the transaction were 782881.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
AMLXAmylyx Pharmaceuticals, Inc.
Filing timeOct 07
Trade dateOct 05, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded3.69%Shares sold ÷ (holdings after + shares sold). Estimated position before: 812,881 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$28.04
Pre-filing
1mo ago +21.6%1w ago +6.5%1d ago -0.9%
Returns since
7d30d90d180d1y

AMLX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AMLX since 2026-10-07Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-416950
Common Stock
Transaction date
Oct 05, 2026
Filed Oct 07, 2026, 08:00 PM · 2d delay
Shares
30.0k sh
$27.70 per share
Estimated value
-$830k
Computed from shares × price
Holdings after
782k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on April 28, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.36 to $28.05. Full information regarding the number of shares sold…

  3. furnished to the SEC staff upon request.

Original filing · 0001193125-26-416950
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AMLX